Teva Pharmaceutical Industries Limited Stock News

Shares of Teva are fluctuating after a report from Bloomberg that the company is considering a sale of its active ingredients business. Yahoo Finance Healthcare Reporter Anjalee Khemlani breaks down t

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2023 financial results on Wednesda

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Bristol Myers Squibb stock is too cheap to ignore. Pfizer has more good news on the way than meets the eye.

New York Attorney General Letitia James announced Friday the final approval of $17.3 billion in national settlement agreements with drug-store chains CVS Health Corp. CVS, and Walgreens Boots Alliance

Teva Pharmaceutical Industries (NASDAQ:TEVA) has agreed to pay the state of Nevada $193 million to settle claims that its marketing efforts helped fuel opioid addiction, the state announced Wednesday.

Teva Pharmaceuticals TEVA, +2.07% announced Thursday that it has resolved its nationwide settlement agreement related to opioid claims brought by states and reached a separate settlement with the stat

Teva Pharmaceutical Industries on Wednesday agreed to pay Nevada $193 million to settle claims that its marketing practices fueled opioid addiction, the state announced.

Teva is refocusing its efforts on biosimilar medicines and cost-cutting. It's also looking to broaden its pipeline more generally to develop more generics.

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that four studies across its

The new corporate strategy aims to deliver a “pivot to growth," the drugmaker said.

Teva announced a new growth strategy. This news sparked an upgrade of the pharma stock by one analyst.

Teva Pharmaceuticals (NYSE: TEVA ) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy. Teva Pharmaceuticals has laid out the four pillars of how it p